Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.
- Resource Type
- Article
- Source
- Liver Cancer (2235-1795); 2023, Vol. 12 Issue 3, p262-276, 15p
- Subject
PROGRESSION-free survival CONTRAST-enhanced magnetic resonance imaging FEATURE extraction MAGNETIC resonance imaging NEUTROPHIL lymphocyte ratio - Language
- ISSN
- 22351795